Logo-npj

Original

1. A clinicopathological study on lupus nephritis; experience of 34 cases from Bangladesh
Muhammad Nazmul Baqui*, Shabnam Akhter, Enamul Kabir, Mohammad Shamiul Islam
J Nephropharmacol. 2016;5(1): 19-23.
Article
PDF
XML
Cited By:
Commentary

2. Lupus nephritis in Bangladesh: unfolding the story
Muhammed Mubarak*
J Nephropharmacol. 2016;5(1): 26-27.
Article
PDF
XML
Cited By:
Case Report

3. Pneumocystis pneumonia in a patient with lupus nephritis
Zain Majid*, Afshan Hussain, Hafsa Jawaid, Shoaib Ahmed, Saima Ahmed, Mohammad Mubarak
J Nephropharmacol. 2018;7(1): 40-42. doi: 10.15171/npj.2018.09
Article
PDF
XML
Cited By:
1
Mini-Review

4. Lupus nephritis in males; updates to current knowledge  
Faizan Shaukat, Liliya Russinova, Bagzhan Seizhanova, Assel Rakhmetova*
J Nephropharmacol. 2019;8(1): e09. doi: 10.15171/npj.2019.09
Article
PDF
XML
Cited By:
2
News and Views

5. Exacerbation of an undiagnosed pre-existing lupus nephritis following an inactivated COVID-19 vaccination

Shakiba Hassanzadeh ORCID, Muhammed Mubarak ORCID, Mohsen Akhavan Sepahi* ORCID, Hamid Nasri* ORCID
J Nephropharmacol. 2022;11(1): e2. doi: 10.34172/npj.2022.02
Scopus ID: 85119605257    
Article
PDF
XML
Cited By:
2
0

Review

6. The efficacy of sodium-glucose cotransporter-2 inhibitors (SGLT2i) on renoprotection in lupus nephritis: a comprehensive review
Shankar Prasad Nagaraju ORCID, Shilna Muttickal Swaminathan ORCID, Priya Rani ORCID, Indu Ramachandra Rao ORCID, Ravindra Prabhu Attur ORCID, Dharshan Rangaswamy ORCID, Srinivas Vinayak Shenoy ORCID, Ankur Gupta ORCID, Mohan V Bhojaraja* ORCID
J Nephropharmacol. 2025;. doi: 10.34172/npj.2025.12724
Article
PDF
XML
Cited By: